Rising patient opt-out rates have prompted UK Health Innovation Minister James Frith to express concern over public mistrust regarding Palantir’s £330 million contract with the National Health Service. According to government figures, 60,000 additional patients withdrew their medical records from research access over a two-month period, leading medical groups to urge the government to exercise a contract break clause.
Palantir defended its platform performance, reporting that participating health trusts achieved 110,000 additional surgical operations and a 15 percent reduction in discharge delays. However, health officials noted that direct cause-and-effect conclusions cannot be drawn, and the national statistics watchdog is reviewing the data while privacy advocates criticize the company’s background and leadership.
The growing public and political pushback has complicated plans for a mandatory platform rollout across local health trusts. Officials warn that sustained increases in patient data opt-outs could hinder long-term health research and national planning efforts that depend on broad dataset access.
Why it matters
Data privacy controversies can severely impede enterprise and public sector AI deployments dependent on sensitive user datasets.
AI vendors in healthcare face high transparency barriers and risk contract cancellations if public trust erodes.
Source: theguardian.com
